Skip to content

Author

S. Dorbala

We have 4 of 158 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 8473: Vascular Dysfunction, Body Composition and Cardiovascular Outcomes in Patients with Diabetes

Background: Diabetes confers increased yet heterogeneous cardiovascular risk. Coronary microvascular dysfunction (CMD) is a robust, independent predictor of adverse outcomes and a key link between metabolic dysregulation and cardiovascular events. Excess visceral and ectopic adiposity, which are features of diabetes...

Carole Kounga, Filipe A. Moura, Lee Joseph et al. · 0 citations
Oct 2026

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry.

BACKGROUND Left ventricular ejection fraction reserve (LVEF-R), defined as stress EF minus rest EF, is a marker for high-risk coronary artery disease in patients undergoing positron emission tomography myocardial perfusion imaging, but its prognostic and diagnostic significance in large real-world populations remains i...

W. Hijazi, Jian-Hang Zhou, Robert J. H. Miller et al. · 0 citations
Review Open access Aug 2026

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

Results support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis and support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis.

S. Dorbala, Mathew S. Maurer, S. Cuddy et al. · 0 citations
Review Open access Jul 2026

Frailty status, clinical and functional outcomes in cardiac amyloidosis: a systematic review and meta-analysis

Findings were consistent across frailty instruments and sensitivity analyses, supporting the incorporation of routine frailty assessment and 6MWD into clinical management of ATTR amyloidosis and supporting the incorporation of routine frailty assessment and 6MWD into clinical management of CA.

Haowen Jiang, D. J. Lim, Chun-Yuan Khoo et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.